末端脱氧核苷酸转移酶

跳转到： 导航, 搜索
A+医学百科 >> 末端脱氧核苷酸转移酶


末端脱氧核苷酸转移酶(Terminal deoxynucleotidyl transferas、TdT、末端转移酶)，是一种特殊的DNA聚合酶，显示出未成熟的、"前B"，"前T淋巴细胞"和"急性淋巴性白血病/淋巴瘤细胞"。"末端转移酶"于"抗体基因重组时"加上N核苷酸(N-nucleotide)至V(D)J的外显子上，能够形成连接多样性(Junctional diversity)的现象。在人类中，末端转移酶是由DNTT基因来编码。 [1][2]

TdT不存在于"胎肝造血干细胞"上，而在胎儿期明显的损害B细胞之连接多样性。[3]

目录

功能

"末端转移酶"催化的加上核苷酸至DNA分子的3'末端。不像大多数的DNA聚合酶，它不需要一个模板。这种酶的优选底物是3'突出端，但它也可以添加"核苷酸"(nucleotifes)至"钝末端"(blunt end)或"凹陷的3'末端"(recessed 3' end)。钴是一种必要的辅因子，但是在酶催化后反应在的镁(Mg)及锰(Mn)施用"体外"(in vitro)。

使用

末端转移酶在分子生物学中的应用。它可以被用来在cDNA末端的快速扩增(RACE)中来添加"核苷酸"(nucleotide)，然后可以用来作为在后续PCR的"引物"(primer)的模板。它也可以用于添加标记放射性同位素的核苷酸，例如在TUNEL检测(末端脱氧核苷酸转移酶"dUTP缺口末端标记"(dUTP Nick End Labeling))，用于细胞凋亡的示范(其中的标记，在某种程度上，通过片段化DNA来进行)。也可用于治疗"急性淋巴性白血病"诊断之"免疫荧光测定"(immuno-fluorescence)。[4]

在免疫组织化学中，抗体TdT酶可用于显示未成熟的T细胞和B细胞以及多能的"造血(Haematopoiesis)干细胞"的存在，其具有抗原，而成熟的淋巴样细胞总是呈"TdT阴性"。而末端转移酶阳性的细胞中发现少量的健康淋巴结和扁桃体，急性淋巴细胞白血病的恶性细胞也呈"TdT阳性"，而抗体，因此可以被用来作为面板诊断及区别这种疾病的一部分，比如，"初发期的小细胞肿瘤"(small cell tumours of childhood)。[5]

参见

注释

  1. ↑ Isobe M, Huebner K, Erikson J, Peterson RC, Bollum FJ, Chang LM, Croce CM. [http//www.ncbi.nlm.nih.gov/pmc/articles/PMC390648/ Chromosome localization of the gene for human terminal deoxynucleotidyltransferase to region 10q23-q25]. Proc. Natl. Acad. Sci. U.S.A.. September 1985, 82 (17): 5836–40. doi:10.1073/pnas.82.17.5836. PMID 3862101. PMC 390648. 
  2. ↑ Yang-Feng TL, Landau NR, Baltimore D, Francke U. The terminal deoxynucleotidyltransferase gene is located on human chromosome 10 (10q23-q24) and on mouse chromosome 19. Cytogenet. Cell Genet.. 1986, 43 (3-4): 121–6. doi:10.1159/000132309. PMID 3467897. 
  3. ↑ Hardy, Richard. Chapter 7: B Lymphocyte Development and Biology//Paul, William. Fundamental Immunology (Book). 6th. Philadelphia: Lippincott Williams & Wilkins. 2008: pp. 237–269. ISBN 0-7817-6519-6. 
  4. ↑ Faber J, Kantarjian H, Roberts MW, Keating M, Freireich E, Albitar M. Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia. Arch. Pathol. Lab. Med.. January 2000, 124 (1): 92–7. PMID 10629138. 
  5. ↑ Leong, Anthony S-Y; Cooper, Kumarason; Leong, F Joel W-M. Manual of Diagnostic Cytology. 2. Greenwich Medical Media, Ltd.. 2003: pp. 413–414. ISBN 1-84110-100-1. 

Further reading

  • O'Malley DP, Orazi A. Terminal deoxynucleotidyl transferase-positive cells in spleen, appendix and branchial cleft cysts in pediatric patients.. Haematologica. 2006, 91 (8): 1139–40. PMID 16885057. 
  • Yamashita N, Shimazaki N, Ibe S, et al.. Terminal deoxynucleotidyltransferase directly interacts with a novel nuclear protein that is homologous to p65.. Genes Cells. 2001, 6 (7): 641–52. doi:10.1046/j.1365-2443.2001.00449.x. PMID 11473582. 
  • Chang LM, Bollum FJ. Molecular biology of terminal transferase.. CRC Crit. Rev. Biochem.. 1986, 21 (1): 27–52. doi:10.3109/10409238609113608. PMID 3524991. 
  • Maezawa S, Hayano T, Koiwai K, et al.. Bood POZ containing gene type 2 is a human counterpart of yeast Btb3p and promotes the degradation of terminal deoxynucleotidyltransferase.. Genes Cells. 2008, 13 (5): 439–57. doi:10.1111/j.1365-2443.2008.01179.x. PMID 18429817. 
  • Taplin ME, Frantz ME, Canning C, et al.. [http//www.ncbi.nlm.nih.gov/pmc/articles/PMC1384108/ Evidence against T-cell development in the adult human intestinal mucosa based upon lack of terminal deoxynucleotidyltransferase expression.]. Immunology. 1996, 87 (3): 402–7. doi:10.1046/j.1365-2567.1996.496571.x. PMID 8778025. PMC 1384108. 
  • Grupe A, Li Y, Rowland C, et al.. [http//www.ncbi.nlm.nih.gov/pmc/articles/PMC1380225/ A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.]. Am. J. Hum. Genet.. 2006, 78 (1): 78–88. doi:10.1086/498851. PMID 16385451. PMC 1380225. 
  • Dworzak MN, Fritsch G, Fröschl G, et al.. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny.. Blood. 1998, 92 (9): 3203–9. PMID 9787156. 
  • Fujita K, Shimazaki N, Ohta Y, et al.. Terminal deoxynucleotidyltransferase forms a ternary complex with a novel chromatin remodeling protein with 82 kDa and core histone.. Genes Cells. 2003, 8 (6): 559–71. doi:10.1046/j.1365-2443.2003.00656.x. PMID 12786946. 
  • Kubota T, Maezawa S, Koiwai K, et al.. Identification of functional domains in TdIF1 and its inhibitory mechanism for TdT activity.. Genes Cells. 2007, 12 (8): 941–59. doi:10.1111/j.1365-2443.2007.01105.x. PMID 17663723. 
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al.. Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.. Gene. 1997, 200 (1-2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149. 
  • Bridges SL. [http//www.ncbi.nlm.nih.gov/pmc/articles/PMC2230400/ Frequent N addition and clonal relatedness among immunoglobulin lambda light chains expressed in rheumatoid arthritis synovia and PBL, and the influence of V lambda gene segment utilization on CDR3 length.]. Mol. Med.. 1998, 4 (8): 525–53. PMID 9742508. PMC 2230400. 
  • Liu L, McGavran L, Lovell MA, et al.. Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia.. Am. J. Clin. Pathol.. 2004, 121 (6): 810–5. doi:10.1309/QD18-PPV1-NH3T-EUTF. PMID 15198352. 
  • Yang B, Gathy KN, Coleman MS. Mutational analysis of residues in the nucleotide binding domain of human terminal deoxynucleotidyl transferase.. J. Biol. Chem.. 1994, 269 (16): 11859–68. PMID 8163485. 
  • Gerhard DS, Wagner L, Feingold EA, et al.. [http//www.ncbi.nlm.nih.gov/pmc/articles/PMC528928/ The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).]. Genome Res.. 2004, 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334. PMC 528928. 
  • Thai TH, Kearney JF. Distinct and opposite activities of human terminal deoxynucleotidyltransferase splice variants.. J. Immunol.. 2004, 173 (6): 4009–19. PMID 15356150. 
  • Shimazaki N, Fujita K, Koiwai O. [Expression and function of terminal deoxynucleotidyl-transferase and discovery of novel DNA polymerase mu]. Seikagaku. 2002, 74 (3): 227–32. PMID 11974916. 
  • Mahajan KN, Mitchell BS. [http//www.ncbi.nlm.nih.gov/pmc/articles/PMC196874/ Role of human Pso4 in mammalian DNA repair and association with terminal deoxynucleotidyl transferase.]. Proc. Natl. Acad. Sci. U.S.A.. 2003, 100 (19): 10746–51. doi:10.1073/pnas.1631060100. PMID 12960389. PMC 196874. 
  • Strausberg RL, Feingold EA, Grouse LH, et al.. [http//www.ncbi.nlm.nih.gov/pmc/articles/PMC139241/ Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.]. Proc. Natl. Acad. Sci. U.S.A.. 2002, 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932. PMC 139241. 
  • Mahajan KN, Gangi-Peterson L, Sorscher DH, et al.. [http//www.ncbi.nlm.nih.gov/pmc/articles/PMC24167/ Association of terminal deoxynucleotidyl transferase with Ku.]. Proc. Natl. Acad. Sci. U.S.A.. 1999, 96 (24): 13926–31. doi:10.1073/pnas.96.24.13926. PMID 10570175. PMC 24167. 
  • Ibe S, Fujita K, Toyomoto T, et al.. Terminal deoxynucleotidyltransferase is negatively regulated by direct interaction with proliferating cell nuclear antigen.. Genes Cells. 2001, 6 (9): 815–24. doi:10.1046/j.1365-2443.2001.00460.x. PMID 11554927. 

外部链接

激酶类（EC 2.7）
2.7.1-2.7.4：磷酸转移酶类/激酶
（PO4）
2.7.1：以羟基为受体
2.7.2：以羧基为受体
2.7.3：以含氮基团为受体
2.7.4：以磷酸基团为受体
2.7.6：二磷酸转移酶类
2.7.7：核苷酸基转移酶
聚合酶
DNA聚合酶
DNA指导的DNA聚合酶
DNA聚合酶Ⅰ
DNA聚合酶Ⅱ
DNA聚合酶Ⅲ全酶
DNA聚合酶Ⅳ
DNA聚合酶Ⅴ
RNA指导的DNA聚合酶
逆转录酶
端粒酶
DNA核苷酸基外转移酶/末端脱氧核苷酸转移酶
RNA核苷酸转移酶
磷酸解作用
由3'端至5'端的核糖核酸外切酶
尿苷酰转移酶
鸟苷酰转移酶
其它
2.7.8：杂项
磷脂酰基转移酶类
糖基-1-磷酸转移酶类
2.7.10-2.7.13：蛋白激酶类
（PO4；蛋白质受体）
2.7.10：蛋白酪氨酸
2.7.11：蛋白丝氨酸/苏氨酸
2.7.12：蛋白双特异性
2.7.13：蛋白组氨酸

参考来源

关于“末端脱氧核苷酸转移酶”的留言： Feed-icon.png 订阅讨论RSS

目前暂无留言

添加留言

更多医学百科条目

个人工具
名字空间
动作
导航
推荐工具
功能菜单
工具箱